List Title | APhA DrugInfoLine

Gastroenterology

SORT BY: Most Recent Most Viewed

July 2, 2018

Corticosteroids for severe alcoholic hepatitis improve short-term outcomes

READ

PREVIEW
According to a study published in Gastroenterology, use of corticosteroids in patients with severe alcoholic hepatitis significantly reduced the risk of death within 28 days when compared...
April 16, 2018

Updated Clostridium difficile guidelines released

READ

PREVIEW
Updated guidelines for management of Clostridium difficile infections in adults and children, published in Clinical Infectious Diseases, focus on diagnosis, infection prevention...
March 13, 2018

PPIs decrease the effectiveness of hepatitis C antivirals

READ

PREVIEW
Sustained virologic responses (SVRs) were lower in patients with hepatitis C taking direct-acting antivirals with proton pump inhibitors (PPIs) compared with those not receiving PPIs, according to...
February 20, 2018

Proton pump inhibitor use not associated with increased risk of stroke

READ

PREVIEW
Routine use of proton pump inhibitors (PPIs) was not associated with a significant increase in the risk of ischemic stroke after adjustment for multiple risk stroke factors and PPI indications,...
December 18, 2017

Gastric cancer risk increased with long-term PPI use

READ

PREVIEW
An increased risk of gastric cancer was observed with long-term proton pump inhibitor (PPI) use even after eradication of Helicobacter pylori infection, according to results of an...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.